There are currently many approved vaccines worldwide for the prevention of COVID-19, with many individuals being at higher risk of contracting the virus than others. Prof. Renslow Sherer (The University of Chicago Medicine, Chicago, IL, USA) discusses the factors increasing the risk of contracting COVID-19, what we have learned about long-term efficacy of mRNA vaccines, and the evidence in favour of a 4th vaccination in older adults.
View more content from Prof. Renslow Sherer: Interventions to reduce transmission of COVID-19
The presentation entitled: ‘COVID-19 Update Part 1: Prevention’ was presented at the American Conference for the Treatment of HIV (ACTHIV), May 5-7, 2022.
Questions:
- What factors increase the risk of severe COVID-19? (0:05)
- What have we learned about the long-term efficacy of mRNA vaccines, and what is the evidence in favour of a 4th vaccination in older adults? (2:19)
Disclosures: Renslow Sherer receives grant/research support from Gilead Sciences
Support: Interview and filming supported by Touch Medical Media. Interview conducted
Access further resources from Prof. Renslow Sherer: Lessons in Resilience – What HIV Teaches Us About COVID-19
